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The N6-methyladenosine (m6A) modification of mRNA
has a crucial function in regulating pluripotency in
murine stem cells: it facilitates resolution of naïve
pluripotency towards differentiation.the best-defined functions of m6A came alongside the
6An old modification rediscovered: m6A in
messenger RNA
Epigenetic modifications of DNA and histones have been
well investigated as crucial factors in the regulation of
gene expression. However, the study of similar chemical
modifications of RNA is still in its infancy. Among them,
N6-methyladenosine (m6A) is the most abundant in-
ternal modification of the messenger RNA of almost all
eukaryotes and of viruses that replicate in nuclei. Des-
pite its existence being reported 40 years ago [1], the
biological function and significance of m6A have only re-
cently entered the research spotlight. The m6A modifica-
tion was found to be dynamic, with the discovery of the
alpha-ketoglutarate-dependent dioxygenase FTO and
RNA demethylase ALKBH5, which are two demethylases
that remove the methyl group from m6A within RNA, as
well as the characterization of N6-adenosine-methyl-
transferase subunits METTL3 and METTL14, two
methyltransferases that methylate adenosine residues to
form m6A in RNA molecules [2-4] (Figure 1a). From
these reports, methylation giving rise to m6A was dem-
onstrated as the first confirmed reversible RNA modifi-
cation, which sparked the re-emergence of research
interest in this modification. Transcriptome-wide profil-
ing of m6A further revealed its distribution pattern in
mammalian cells and tissues [5,6]. It has a predominant
sequence consensus and is strongly enriched around
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unless otherwise stated.transcription start sites. These features suggest that m6A
performs functional roles in regulation.
As the most abundant internal modification in mam-
malian mRNA, m6A is involved in multiple aspects of
RNA metabolism, including RNA stability, translation,
splicing, transport and localization (Figure 1a). One of
discovery and characterization of the first m A-specific
binding protein, the YTH domain-containing family pro-
tein 2 (YTHDF2) [5,7]. YTHDF2 alters the overall stability
of m6A-containing mRNAs by causing their relocalization
to specialized mRNA-decay machineries, where they are
committed to degradation. Other data also suggest roles
for m6A in mRNA export and translation.
The modification m6A is essential in mammals and
has been suggested to impact cell differentiation and de-
velopment. Researchers have been probing the involve-
ment of m6A in mouse and human embryonic stem cells
(ESCs), but have produced somewhat conflicting results.
Wang and colleagues [8] had reported in 2014 that
knockdown of Mettl3 and Mettl14 in murine ESCs
(mESCs) resulted in reduced m6A abundance and de-
fective cell regeneration. Yet, in a more recent study,
Batista and colleagues [9] found that complete knockout
of Mettl3 in mESCs led to improved self-renewal and re-
sulted in blocked differentiation. In the latest paper on
this topic, published in Science, Geula and colleagues
[10] confirm the crucial roles of m6A methylation in the
differentiation of mESCs and present a detailed demon-
stration of how depletion of m6A drives mESCs at naїve
or primed pluripotency states to divergent fates.m6A as a fate determiner in murine embryonic
stem cells
Geula and colleagues started by screening for factors es-
sential for maintenance of pluripotency and identified
several candidates. Among them, METLL3 emerged as a
crucial component for regulation of stem cell pluripo-
tency. The pluripotent stage can be further divided into
two states: a ground, naїve state, and a differentiation-l. This is an Open Access article distributed under the terms of the Creative
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Figure 1 The establishment and role of m6A RNA methylation in development. (a) RNA methylation is dynamically regulated and impacts
various aspects of RNA metabolism. The m6A marker is created by the activity of the m6A methyltransferase complex (METTL3-METTL14), and the
methyl group can be reversibly removed by m6A demethylases; the modification can be recognized by m6A-binding proteins to effect biological
functions. (b) Divergent effects of depletion through knockout (KO) of the N6-adenosine-methyltransferase subunit METTL3 during naïve and
primed pluripotent states. As m6A reduces the stability of methylated transcripts, depletion of METTL3 in naïve pluripotent cells further upregulates the
already-high naïve pluripotency genes to create a ‘hyper’-naïve pluripotent state, whereas depletion during the primed state further boosts the dominating
lineage-commitment factors and tips the balance towards differentiation.
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vestigated the pluripotent stem cells at naїve (ESC) and
primed (epiblast stem cell, EpiSC) states along with the
respective impacts of m6A. To dissect the roles of
METTL3 and m6A in the naїve pluripotent state, hetero-
zygous Mettl3+/− mice were generated, and homozygous
Mettl3−/− mESCs were obtained from embryos. In con-
trast to wild-type cells, Mettl3−/− cells generated partially
differentiated embryoid bodies (EBs), failed to produce
mature neurons and were unable to proceed into a primed
state upon corresponding inductions in vitro. Similarly,
when these cells were injected into immunodeficient micein vivo, the teratomas generated were poorly differenti-
ated. These data indicate that the depletion of METTL3,
and hence m6A, blocks differentiation in mESCs and
keeps them in a so-called hyper-naїve state. By contrast,
the depletion of METTL3 and m6A in the primed EpiSCs
during a primed pluripotent state produced the opposite
spectrum of effects - this depletion led to minimal self-
renewal and fast differentiation, ultimately disrupting the
stability of the primed state and resulting in cell death.
Thus, the roles of depletion of METTL3 in this state are
to reduce stem cell self-renewal and push them towards
differentiation (Figure 1b).
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by subsequent high-throughput sequencing analysis.
Transcriptome-wide profiling of m6A (m6A-seq) was per-
formed in ESCs, EBs and mature mouse cells. The results
revealed that 80% of transcripts of naїve pluripotency genes
and multiple lineage-commitment genes are methylated.
Thus, m6A affects the genes governing both the naїve and
primed states. Subsequent measurements of the global
level and life-time of transcripts revealed that methylation
shortens the half-life of modified mRNAs and reduces their
abundance. Therefore, depletion of METTL3 increases the
abundance and dominance of already-expressed genes,
which leads to the observed phenotypes. For instance, in
the naїve state, pluripotency genes predominate. Without
m6A methylation, cells become stuck at the so-called
hyper-pluripotent state, with high levels of expression of
pluripotent transcripts. By contrast, at the primed state,
lineage-commitment genes prevail, and removing m6A fur-
ther tips the balance towards differentiation (Figure 1b).
Taking their findings further, the authors carefully mea-
sured the expression of both pluripotency and differenti-
ation genes in Mettl3−/− embryos before they died. It was
found that the widespread expression of the pluripotency
marker Nanog (encoding homeobox protein Nanog) was
prolonged; and, although the expression of the differenti-
ation marker Pou5f1 (encoding transcription factor Oct4)
was maintained, other lineage-commitment genes were
not upregulated in the way that they are in wild-type em-
bryos. Thus, knockout cells were in a naїve-like state, with
a certain level of priming, exhibiting resistance to progres-
sion of differentiation. These in vivo findings are in good
accord with the observed mESC phenotypes.
Unifying mechanisms under a plethora of
phenotypes
All the studies performed to date demonstrate that the
presence of m6A reduces the stability of methylated
mRNA transcripts in mESCs. Phenotypes are deter-
mined by the dominating type of transcripts, and m6A
depletion works to intensify the trend. Although the au-
thors did not explain how m6A affects mRNA stability,
previous studies indicate that YTHDF2 could be partially
responsible [6]. However, regulating mRNA stability is
but one confirmed function of m6A. In this work, Geula
and colleagues additionally suggest that m6A might in-
crease the splicing efficiency of unfavored splicing
events. Other aspects of RNA processing could also be
affected by methylation and contribute to the observed
phenotypes. In principle, with each discovered m6A-spe-
cific binding protein (or m6A 'reader'), there will be a
corresponding function associated with m6A. Therefore,
further research to identify and characterize m6A-specific
binding proteins is important for uncovering the functions
of mRNA m6A methylation. Studies of these readerproteins and their roles could provide underlying mecha-
nisms for cell differentiation and development phenotypes
associated with m6A.
Concluding remarks
In summary, the comprehensive work presented by
Geula et al. reveals m6A as a timely maintainer of the
balance between pluripotency and lineage priming fac-
tors, thus ensuring orderly differentiation of mESCs.
The authors have shown that m6A in mRNA might work
as a ‘plug-in’ to other pre-existing pathways by altering
downsteam gene expression. In this manner, RNA modi-
fications can promote a fast response to external cues
during times of cellular transformation or differentiation.
We fully anticipate additional future discoveries that
connect modifications of mRNA with the regulation of
gene expression in cell differentiation and development
in this fast-growing field.
Abbreviations
EB: Embryoid body; EpiSC: Epiblast stem cell; mESC: Murine embryonic stem cell;
m6A: N6-methyladenosine.
Competing interests
The authors declare that they have no competing interest.
References
1. Desrosiers R, Friderici K, Rottman F. Characterization of Novikoff hepatoma
messenger-RNA methylation. Federation Proc. 1975;34:628.
2. Jia GF, Fu Y, Zhao X, Dai Q, Zheng GQ, Yang Y, et al. N6-Methyladenosine in
nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem
Biol. 2011;7:885–7.
3. Zheng GQ, Dahl JA, Niu YM, Fedorcsak P, Huang CM, Li CJ, et al. ALKBH5 is
a mammalian RNA demethylase that impacts RNA metabolism and mouse
fertility. Mol Cell. 2013;49:18–29.
4. Liu JZ, Yue YN, Han DL, Wang X, Fu Y, Zhang L, et al. A METTL3-METTL14
complex mediates mammalian nuclear RNA N-6-adenosine methylation. Nat
Chem Biol. 2014;10:93–5.
5. Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L,
Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes
revealed by m6A-seq. Nature. 2012;485:201–6.
6. Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR.
Comprehensive analysis of mRNA methylation reveals enrichment in
3′ UTRs and near stop codons. Cell. 2012;149:1635–46.
7. Wang X, Lu ZK, Gomez A, Hon GC, Yue YN, Han DL, et al. N-6-methyladenosine-
dependent regulation of messenger RNA stability. Nature. 2014;505:117–20.
8. Wang Y, Li Y, Toth JI, Petroski MD, Zhang ZL, Zhao JC. N-6-methyladenosine
modification destabilizes developmental regulators in embryonic stem cells.
Nat Cell Biol. 2014;16:191–8.
9. Batista PJ, Molinie B, Wang J, Qu K, Zhang J, Li L, et al. m6A RNA modification
controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell.
2014;15:707–19.
10. Geula S, Moshitch-Moshkovitz S, Dominissini D, Mansour AA, Kol N, Salmon-
Divon M, et al. m6A mRNA methylation facilitates resolution of naïve
pluripotency toward differentiation. Science. 2015;1261417.
